At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.
Category
  • General RO
  • Head and Neck
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Prophylactic Feeding Tube Placement in Head and Neck Cancer: Hard to Swallow?
The clinical practice regarding feeding tube use in patients undergoing radiotherapy for head and neck cancer varies greatly. Ongoing research advances, as well as indications for feeding tube use in contemporary practices are required to provide optimal care.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity in the Community Setting
Patients with head and neck cancer require specialized and multi-modality support during treatment. Providers may not be informed of the most up-to-date techniques to prevent and treat head and neck cancer radiation-related toxicity.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
The use of HPV ctDNA in the clinical management of patients with HPV-associated oropharyngeal squamous cell carcinoma is rapidly increasing; however, questions remain regarding its utility and validity in various clinical settings.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
This case-based activity is designed to provide learners with practical guidance on management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and highlight areas of uncertainty where there may be a range of acceptable treatment approaches.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Neoadjuvant Immunotherapy in Head and Neck Cancer, Sarcoma and Cutaneous Malignancies
Recent landmark studies in melanoma, cutaneous squamous cell carcinoma (cSCC), head and neck cancer (HNC) and sarcoma have established neoadjuvant immune therapy as a potential standard of care for patients with locally advanced cancers.
Category
  • Head and Neck
  • Immunotherapy
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Management of Locally Recurrent Head and Neck Cancer
Locally recurrent HNSCC in the setting of prior radiation therapy is a challenging clinical scenario.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
Palliative Radiation for Head & Neck and Cutaneous Malignancies
This session provides an overview about palliative radiation for head and neck and skin malignancies. It focuses on a brief review of the available evidence supporting palliative radiation therapy for these diseases and help participants identify resources to help guide them in application.
Category
  • Head and Neck
  • Palliative Care
  • Skin
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00